Urinary metabolomic signatures associated with early adverse events during volumetric modulated arc therapy for prostate cancer: A secondary analysis of a public dataset
Molecular and Clinical Oncology · 04.05.2026 · 25 (1) · 1-8
DOI: 10.3892/mco.2026.2953 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Clinical Oncology, online erschienen am 04.05.2026. Verfasst von Mai Fukushi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Science, Hirosaki University Graduate School of Health Sciences, Hirosaki, Aomori 036-8564, Japan. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Science, Hirosaki University Graduate School of Health Sciences, Hirosaki, Aomori 036-8564, Japan.
- Department of Stress Response Science, Biomedical Research Center, Graduate School of Medicine, Hirosaki University, Hirosaki, Aomori 036-8562, Japan.
- Department of Radiology, Hirosaki University Hospital, Hirosaki, Aomori 036-8563, Japan.
- Research Center for Biomedical Sciences, Hirosaki University, Hirosaki Graduate School of Health Sciences, Hirosaki, Aomori 036-8564, Japan.
Zitieren
APA
Fukushi, M., Tatara, Y., Obara, H., & Monzen, S. (2026). Urinary metabolomic signatures associated with early adverse events during volumetric modulated arc therapy for prostate cancer: A secondary analysis of a public dataset. Molecular and Clinical Oncology, 25(1), 1-8. https://doi.org/10.3892/mco.2026.2953
Vancouver
Fukushi M, Tatara Y, Obara H, Monzen S. Urinary metabolomic signatures associated with early adverse events during volumetric modulated arc therapy for prostate cancer: A secondary analysis of a public dataset. Molecular and Clinical Oncology. 2026;25(1):1-8. doi:10.3892/mco.2026.2953
BibTeX
@article{Fukushi2026,
author = {Fukushi, Mai and Tatara, Yota and Obara, Hideki and Monzen, Satoru},
title = {Urinary metabolomic signatures associated with early adverse events during volumetric modulated arc therapy for prostate cancer: A secondary analysis of a public dataset},
journal = {Molecular and Clinical Oncology},
year = {2026},
volume = {25},
number = {1},
pages = {1--8},
doi = {10.3892/mco.2026.2953}
}
EUVIMED